NATIXIS - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 186 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
NATIXIS ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,301,124
-9.4%
296,155
+12.9%
0.02%
-14.3%
Q2 2023$2,538,638
-81.1%
262,256
-78.6%
0.02%
-82.6%
Q1 2023$13,431,338
+218.9%
1,225,487
+25.7%
0.12%
+404.2%
Q4 2022$4,211,754
+331.1%
974,943
+662.0%
0.02%
+380.0%
Q3 2022$977,000
-90.1%
127,945
-87.2%
0.01%
-86.1%
Q2 2022$9,910,000
-20.0%
1,000,0000.0%0.04%
-16.3%
Q1 2022$12,380,000
+8.3%
1,000,000
+100.0%
0.04%
+10.3%
Q4 2021$11,435,000500,0000.04%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders